Industry Context — Common BS Fingerprints in Medical Devices, Pharma & Biotech
Generic Claims:
advancing human health, breakthrough innovation, life-changing therapies, transforming patient outcomes…
Red Flags:
FDA cleared used interchangeably with FDA approved, clinical claims without published study citations, breakthrough claims for incremental improvements, regulatory status implied but not specified…
Semantic Drift Patterns:
homepage claims breakthrough but pipeline page shows preclinical only, FDA approved claims but only for one indication, marketed broadly, claims clinical evidence but links to poster presentations not published studies, claims global reach but regulatory approvals are single-market…
Proof Expectations:
specific regulatory clearance numbers (FDA 510(k), CE, TGA), published clinical trial results with ClinicalTrials.gov registration, ISO 13485 and GMP certification details, peer-reviewed publication citations…
AstraZeneca
(https://onglyza.com) 📸 Data Snapshot: May 31, 2026Analyze the raw signals below. How would a machine score this business’s credibility?
Here are the exact signals captured from up to six pages of the site — the same raw inputs the evaluation engine analyzed. They are grouped by signal type so you can weigh each the way the machine does.
🏗️ Semantic Structure — heading hierarchy & page identity (Info Density · Commodity Fingerprint)
HOMEPAGE AstraZeneca Medications (https://onglyza.com)
Title
AstraZeneca Medications
H1 AstraZeneca medications
H2 The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only.
H2 Help affording your medicines
H3 AIRSUPRA™ (albuterol/budesonide)
H3 ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo
H3 BAXFENDY® (baxdrostat) Tablets
H3 BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol
H3 BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol
H3 BRILINTA® (ticagrelor) tablets
H3 BYDUREON BCise® (exenatide extended-release) injectable suspension
H3 BYETTA® (exenatide) injection
H3 CALQUENCE® (acalabrutinib) tablets
H3 CRESTOR® (rosuvastatin) Tablets
H3 DALIRESP® (roflumilast) tablets
H3 ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use
H3 EPANOVA® (omega-3-carboxylic acids) Capsules
H3 FARXIGA® (dapagliflozin) tablets
H3 FASENRA® (benralizumab) injection, for subcutaneous use
H3 FASLODEX® (fulvestrant) injection, for intramuscular use
H3 FLUMIST® (Influenza Vaccine Live, Intranasal)
H3 IMFINZI® (durvalumab) injection, for intravenous use
H3 IRESSA® (gefitinib)
H3 KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets
H3 LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension
H3 LYNPARZA® (olaparib) tablets
H3 NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension
H3 NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension
H3 NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use
H3 ONGLYZA® (saxagliptin) tablets
H3 PULMICORT RESPULES® (budesonide inhalation suspension)
H3 QTERN® (dapagliflozin and saxagliptin) tablets
H3 SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use
H3 SEROQUEL® (quetiapine) tablets
H3 SEROQUEL XR® (quetiapine) Extended-release tablets
H3 SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol
H3 SYMLIN® (pramlintide acetate) injection
H3 TAGRISSO® (osimertinib) tablets
H3 TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use
H3 TRUQAP™ (capivasertib)
H3 WAINUA™ (eplontersen)
H3 XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets
H3 Global site
H3 Resources
H3 Quick links
H3 Social Media
H4 utility links
NAV_HEADING_REPEATED_BODY_FOOTER AstraZeneca Medications (https://onglyza.com/medicines/Affordability.html)
Title
AstraZeneca Medications
H1 AstraZeneca medications
H2 The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only.
H2 Help affording your medicines
H3 AIRSUPRA™ (albuterol/budesonide)
H3 ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo
H3 BAXFENDY® (baxdrostat) Tablets
H3 BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol
H3 BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol
H3 BRILINTA® (ticagrelor) tablets
H3 BYDUREON BCise® (exenatide extended-release) injectable suspension
H3 BYETTA® (exenatide) injection
H3 CALQUENCE® (acalabrutinib) tablets
H3 CRESTOR® (rosuvastatin) Tablets
H3 DALIRESP® (roflumilast) tablets
H3 ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use
H3 EPANOVA® (omega-3-carboxylic acids) Capsules
H3 FARXIGA® (dapagliflozin) tablets
H3 FASENRA® (benralizumab) injection, for subcutaneous use
H3 FASLODEX® (fulvestrant) injection, for intramuscular use
H3 FLUMIST® (Influenza Vaccine Live, Intranasal)
H3 IMFINZI® (durvalumab) injection, for intravenous use
H3 IRESSA® (gefitinib)
H3 KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets
H3 LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension
H3 LYNPARZA® (olaparib) tablets
H3 NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension
H3 NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension
H3 NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use
H3 ONGLYZA® (saxagliptin) tablets
H3 PULMICORT RESPULES® (budesonide inhalation suspension)
H3 QTERN® (dapagliflozin and saxagliptin) tablets
H3 SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use
H3 SEROQUEL® (quetiapine) tablets
H3 SEROQUEL XR® (quetiapine) Extended-release tablets
H3 SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol
H3 SYMLIN® (pramlintide acetate) injection
H3 TAGRISSO® (osimertinib) tablets
H3 TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use
H3 TRUQAP™ (capivasertib)
H3 WAINUA™ (eplontersen)
H3 XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets
H3 Global site
H3 Resources
H3 Quick links
H3 Social Media
H4 utility links
NAV_HEADING_REPEATED_FOOTER AstraZeneca Medications (https://onglyza.com/az-in-us.html)
Title
AstraZeneca Medications
H1 AstraZeneca medications
H2 The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only.
H2 Help affording your medicines
H3 AIRSUPRA™ (albuterol/budesonide)
H3 ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo
H3 BAXFENDY® (baxdrostat) Tablets
H3 BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol
H3 BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol
H3 BRILINTA® (ticagrelor) tablets
H3 BYDUREON BCise® (exenatide extended-release) injectable suspension
H3 BYETTA® (exenatide) injection
H3 CALQUENCE® (acalabrutinib) tablets
H3 CRESTOR® (rosuvastatin) Tablets
H3 DALIRESP® (roflumilast) tablets
H3 ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use
H3 EPANOVA® (omega-3-carboxylic acids) Capsules
H3 FARXIGA® (dapagliflozin) tablets
H3 FASENRA® (benralizumab) injection, for subcutaneous use
H3 FASLODEX® (fulvestrant) injection, for intramuscular use
H3 FLUMIST® (Influenza Vaccine Live, Intranasal)
H3 IMFINZI® (durvalumab) injection, for intravenous use
H3 IRESSA® (gefitinib)
H3 KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets
H3 LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension
H3 LYNPARZA® (olaparib) tablets
H3 NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension
H3 NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension
H3 NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use
H3 ONGLYZA® (saxagliptin) tablets
H3 PULMICORT RESPULES® (budesonide inhalation suspension)
H3 QTERN® (dapagliflozin and saxagliptin) tablets
H3 SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use
H3 SEROQUEL® (quetiapine) tablets
H3 SEROQUEL XR® (quetiapine) Extended-release tablets
H3 SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol
H3 SYMLIN® (pramlintide acetate) injection
H3 TAGRISSO® (osimertinib) tablets
H3 TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use
H3 TRUQAP™ (capivasertib)
H3 WAINUA™ (eplontersen)
H3 XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets
H3 Global site
H3 Resources
H3 Quick links
H3 Social Media
H4 utility links
NAV_HEADING_REPEATED_FOOTER AstraZeneca Medications (https://onglyza.com/medicines/astrazeneca-medications.html)
Title
AstraZeneca Medications
H1 AstraZeneca medications
H2 The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only.
H2 Help affording your medicines
H3 AIRSUPRA™ (albuterol/budesonide)
H3 ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo
H3 BAXFENDY® (baxdrostat) Tablets
H3 BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol
H3 BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol
H3 BRILINTA® (ticagrelor) tablets
H3 BYDUREON BCise® (exenatide extended-release) injectable suspension
H3 BYETTA® (exenatide) injection
H3 CALQUENCE® (acalabrutinib) tablets
H3 CRESTOR® (rosuvastatin) Tablets
H3 DALIRESP® (roflumilast) tablets
H3 ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use
H3 EPANOVA® (omega-3-carboxylic acids) Capsules
H3 FARXIGA® (dapagliflozin) tablets
H3 FASENRA® (benralizumab) injection, for subcutaneous use
H3 FASLODEX® (fulvestrant) injection, for intramuscular use
H3 FLUMIST® (Influenza Vaccine Live, Intranasal)
H3 IMFINZI® (durvalumab) injection, for intravenous use
H3 IRESSA® (gefitinib)
H3 KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets
H3 LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension
H3 LYNPARZA® (olaparib) tablets
H3 NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension
H3 NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension
H3 NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use
H3 ONGLYZA® (saxagliptin) tablets
H3 PULMICORT RESPULES® (budesonide inhalation suspension)
H3 QTERN® (dapagliflozin and saxagliptin) tablets
H3 SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use
H3 SEROQUEL® (quetiapine) tablets
H3 SEROQUEL XR® (quetiapine) Extended-release tablets
H3 SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol
H3 SYMLIN® (pramlintide acetate) injection
H3 TAGRISSO® (osimertinib) tablets
H3 TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use
H3 TRUQAP™ (capivasertib)
H3 WAINUA™ (eplontersen)
H3 XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets
H3 Global site
H3 Resources
H3 Quick links
H3 Social Media
H4 utility links
📝 The Narrative — clean text per page (Info Density · Semantic Coherence)
HOMEPAGE (https://onglyza.com) AstraZeneca Medications
[H2] The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only. In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AZ Information Center at 1-800-236-9933. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. [H2] Help affording your medicines We believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. Learn more [H3] AIRSUPRA™ (albuterol/budesonide) Prescribing Information Consumer site Health care professional site [H3] ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo Prescribing Information Consumer site Health care professional site [H3] BAXFENDY® (baxdrostat) Tablets Prescribing Information Consumer site Health care professional site [H3] BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site [H3] BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] BRILINTA® (ticagrelor) tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] BYDUREON BCise® (exenatide extended-release) injectable suspension Prescribing Information including Boxed WARNING [H3] BYETTA® (exenatide) injection Prescribing Information [H3] CALQUENCE® (acalabrutinib) tablets Prescribing Information Consumer site Health care professional site [H3] CRESTOR® (rosuvastatin) Tablets Prescribing Information Consumer site Health care professional site [H3] DALIRESP® (roflumilast) tablets Prescribing Information Consumer site Health care professional site [H3] ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use Prescribing Information including Boxed WARNING Health care professional site [H3] EPANOVA® (omega-3-carboxylic acids) Capsules Prescribing Information [H3] FARXIGA® (dapagliflozin) tablets Prescribing Information Consumer site Health care professional site [H3] FASENRA® (benralizumab) injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] FASLODEX® (fulvestrant) injection, for intramuscular use Prescribing Information [H3] FLUMIST® (Influenza Vaccine Live, Intranasal) Prescribing Information Consumer site Health care professional site [H3] IMFINZI® (durvalumab) injection, for intravenous use Prescribing Information Consumer website Health care professional website [H3] IRESSA® (gefitinib) Prescribing Information [H3] KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING [H3] LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension Prescribing Information Consumer site Health care professional site [H3] LYNPARZA® (olaparib) tablets Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use Prescribing Information [H3] ONGLYZA® (saxagliptin) tablets Prescribing Information [H3] PULMICORT RESPULES® (budesonide inhalation suspension) Prescribing Information [H3] QTERN® (dapagliflozin and saxagliptin) tablets Prescribing Information [H3] SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use Prescribing Information Consumer site Health care professional site [H3] SEROQUEL® (quetiapine) tablets Prescribing Information including Boxed WARNINGS [H3] SEROQUEL XR® (quetiapine) Extended-release tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] SYMLIN® (pramlintide acetate) injection Prescribing Information including Boxed WARNING [H3] TAGRISSO® (osimertinib) tablets Prescribing Information Consumer site Health care professional site [H3] TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] TRUQAP™ (capivasertib) Prescribing Information Consumer site Health care professional site [H3] WAINUA™ (eplontersen) Prescribing Information [H3] XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING
5246 chars
SUB-PAGE (https://onglyza.com/medicines/Affordability.html) AstraZeneca Medications
[H2] The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only. In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AZ Information Center at 1-800-236-9933. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. [H2] Help affording your medicines We believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. Learn more [H3] AIRSUPRA™ (albuterol/budesonide) Prescribing Information Consumer site Health care professional site [H3] ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo Prescribing Information Consumer site Health care professional site [H3] BAXFENDY® (baxdrostat) Tablets Prescribing Information Consumer site Health care professional site [H3] BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site [H3] BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] BRILINTA® (ticagrelor) tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] BYDUREON BCise® (exenatide extended-release) injectable suspension Prescribing Information including Boxed WARNING [H3] BYETTA® (exenatide) injection Prescribing Information [H3] CALQUENCE® (acalabrutinib) tablets Prescribing Information Consumer site Health care professional site [H3] CRESTOR® (rosuvastatin) Tablets Prescribing Information Consumer site Health care professional site [H3] DALIRESP® (roflumilast) tablets Prescribing Information Consumer site Health care professional site [H3] ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use Prescribing Information including Boxed WARNING Health care professional site [H3] EPANOVA® (omega-3-carboxylic acids) Capsules Prescribing Information [H3] FARXIGA® (dapagliflozin) tablets Prescribing Information Consumer site Health care professional site [H3] FASENRA® (benralizumab) injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] FASLODEX® (fulvestrant) injection, for intramuscular use Prescribing Information [H3] FLUMIST® (Influenza Vaccine Live, Intranasal) Prescribing Information Consumer site Health care professional site [H3] IMFINZI® (durvalumab) injection, for intravenous use Prescribing Information Consumer website Health care professional website [H3] IRESSA® (gefitinib) Prescribing Information [H3] KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING [H3] LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension Prescribing Information Consumer site Health care professional site [H3] LYNPARZA® (olaparib) tablets Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use Prescribing Information [H3] ONGLYZA® (saxagliptin) tablets Prescribing Information [H3] PULMICORT RESPULES® (budesonide inhalation suspension) Prescribing Information [H3] QTERN® (dapagliflozin and saxagliptin) tablets Prescribing Information [H3] SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use Prescribing Information Consumer site Health care professional site [H3] SEROQUEL® (quetiapine) tablets Prescribing Information including Boxed WARNINGS [H3] SEROQUEL XR® (quetiapine) Extended-release tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] SYMLIN® (pramlintide acetate) injection Prescribing Information including Boxed WARNING [H3] TAGRISSO® (osimertinib) tablets Prescribing Information Consumer site Health care professional site [H3] TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] TRUQAP™ (capivasertib) Prescribing Information Consumer site Health care professional site [H3] WAINUA™ (eplontersen) Prescribing Information [H3] XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING
5246 chars
SUB-PAGE (https://onglyza.com/az-in-us.html) AstraZeneca Medications
[H2] The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only. In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AZ Information Center at 1-800-236-9933. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. [H2] Help affording your medicines We believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. Learn more [H3] AIRSUPRA™ (albuterol/budesonide) Prescribing Information Consumer site Health care professional site [H3] ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo Prescribing Information Consumer site Health care professional site [H3] BAXFENDY® (baxdrostat) Tablets Prescribing Information Consumer site Health care professional site [H3] BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site [H3] BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] BRILINTA® (ticagrelor) tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] BYDUREON BCise® (exenatide extended-release) injectable suspension Prescribing Information including Boxed WARNING [H3] BYETTA® (exenatide) injection Prescribing Information [H3] CALQUENCE® (acalabrutinib) tablets Prescribing Information Consumer site Health care professional site [H3] CRESTOR® (rosuvastatin) Tablets Prescribing Information Consumer site Health care professional site [H3] DALIRESP® (roflumilast) tablets Prescribing Information Consumer site Health care professional site [H3] ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use Prescribing Information including Boxed WARNING Health care professional site [H3] EPANOVA® (omega-3-carboxylic acids) Capsules Prescribing Information [H3] FARXIGA® (dapagliflozin) tablets Prescribing Information Consumer site Health care professional site [H3] FASENRA® (benralizumab) injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] FASLODEX® (fulvestrant) injection, for intramuscular use Prescribing Information [H3] FLUMIST® (Influenza Vaccine Live, Intranasal) Prescribing Information Consumer site Health care professional site [H3] IMFINZI® (durvalumab) injection, for intravenous use Prescribing Information Consumer website Health care professional website [H3] IRESSA® (gefitinib) Prescribing Information [H3] KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING [H3] LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension Prescribing Information Consumer site Health care professional site [H3] LYNPARZA® (olaparib) tablets Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use Prescribing Information [H3] ONGLYZA® (saxagliptin) tablets Prescribing Information [H3] PULMICORT RESPULES® (budesonide inhalation suspension) Prescribing Information [H3] QTERN® (dapagliflozin and saxagliptin) tablets Prescribing Information [H3] SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use Prescribing Information Consumer site Health care professional site [H3] SEROQUEL® (quetiapine) tablets Prescribing Information including Boxed WARNINGS [H3] SEROQUEL XR® (quetiapine) Extended-release tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] SYMLIN® (pramlintide acetate) injection Prescribing Information including Boxed WARNING [H3] TAGRISSO® (osimertinib) tablets Prescribing Information Consumer site Health care professional site [H3] TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] TRUQAP™ (capivasertib) Prescribing Information Consumer site Health care professional site [H3] WAINUA™ (eplontersen) Prescribing Information [H3] XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING
5246 chars
SUB-PAGE (https://onglyza.com/medicines/astrazeneca-medications.html) AstraZeneca Medications
[H2] The list below contains full Prescribing Information for all of our medicines and a range of websites dedicated to providing you with product-specific information. The information contained below is intended for US residents only. In order to monitor the safety of AstraZeneca products, we encourage reporting any side effects experienced while taking an AstraZeneca product to the AZ Information Center at 1-800-236-9933. Alternatively, you can report any side effects of prescription drugs directly to the FDA. Visit www.FDA.gov/medwatch or call 1-800-FDA-1088. [H2] Help affording your medicines We believe it’s not enough for us to simply make medicines. We have to make sure that the people who need those medicines can get them. Learn more [H3] AIRSUPRA™ (albuterol/budesonide) Prescribing Information Consumer site Health care professional site [H3] ANDEXXA® Coagulation Factor Xa (recombinant), inactivated-zhzo Prescribing Information Consumer site Health care professional site [H3] BAXFENDY® (baxdrostat) Tablets Prescribing Information Consumer site Health care professional site [H3] BEVESPI AEROSPHERE® (glycopyrrolate and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site [H3] BREZTRI AEROSPHERE® (budesonide, glycopyrrolate, and formoterol fumarate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] BRILINTA® (ticagrelor) tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] BYDUREON BCise® (exenatide extended-release) injectable suspension Prescribing Information including Boxed WARNING [H3] BYETTA® (exenatide) injection Prescribing Information [H3] CALQUENCE® (acalabrutinib) tablets Prescribing Information Consumer site Health care professional site [H3] CRESTOR® (rosuvastatin) Tablets Prescribing Information Consumer site Health care professional site [H3] DALIRESP® (roflumilast) tablets Prescribing Information Consumer site Health care professional site [H3] ENHERTU® (fam-trastuzumab deruxtecan-nxki) injection for intravenous use Prescribing Information including Boxed WARNING Health care professional site [H3] EPANOVA® (omega-3-carboxylic acids) Capsules Prescribing Information [H3] FARXIGA® (dapagliflozin) tablets Prescribing Information Consumer site Health care professional site [H3] FASENRA® (benralizumab) injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] FASLODEX® (fulvestrant) injection, for intramuscular use Prescribing Information [H3] FLUMIST® (Influenza Vaccine Live, Intranasal) Prescribing Information Consumer site Health care professional site [H3] IMFINZI® (durvalumab) injection, for intravenous use Prescribing Information Consumer website Health care professional website [H3] IRESSA® (gefitinib) Prescribing Information [H3] KOMBIGLYZE® XR (saxagliptin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING [H3] LOKELMA® (sodium zirconium cyclosilicate) 10 g for oral suspension Prescribing Information Consumer site Health care professional site [H3] LYNPARZA® (olaparib) tablets Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) delayed-release capsules, for oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® (esomeprazole magnesium) for delayed-release oral suspension Prescribing Information Consumer site Health care professional site [H3] NEXIUM® I.V. (esomeprazole sodium) for injection, for intravenous use Prescribing Information [H3] ONGLYZA® (saxagliptin) tablets Prescribing Information [H3] PULMICORT RESPULES® (budesonide inhalation suspension) Prescribing Information [H3] QTERN® (dapagliflozin and saxagliptin) tablets Prescribing Information [H3] SAPHNELO® (anifrolumab-fnia) Injection, for intravenous use Prescribing Information Consumer site Health care professional site [H3] SEROQUEL® (quetiapine) tablets Prescribing Information including Boxed WARNINGS [H3] SEROQUEL XR® (quetiapine) Extended-release tablets Prescribing Information including Boxed WARNINGS Consumer site Health care professional site [H3] SYMBICORT® (budesonide and formoterol fumarate dihydrate) Inhalation Aerosol Prescribing Information Consumer site Health care professional site [H3] SYMLIN® (pramlintide acetate) injection Prescribing Information including Boxed WARNING [H3] TAGRISSO® (osimertinib) tablets Prescribing Information Consumer site Health care professional site [H3] TEZSPIRE® (tezepelumab-ekko) Injection, for subcutaneous use Prescribing Information Consumer site Health care professional site [H3] TRUQAP™ (capivasertib) Prescribing Information Consumer site Health care professional site [H3] WAINUA™ (eplontersen) Prescribing Information [H3] XIGDUO® XR (dapagliflozin and metformin HCl extended-release) tablets Prescribing Information including Boxed WARNING
5246 chars
🛡️ Trust Signals — reviews, proof links, trust-theatre flag (Trust & Proof)
0Review mentions (all pages)
4External proof links (all pages)
| Page | Reviews | Proof links |
|---|---|---|
| / (home) | 0 | 1 |
| /medicines/Affordability.html | 0 | 1 |
| /az-in-us.html | 0 | 1 |
| /medicines/astrazeneca-medications.html | 0 | 1 |
🔗 Identity & Technical Layer — schema JSON-LD: identity chains, entity gaps (Identity & Authority)
Homepage — no schema detected (entity gap)
/medicines/Affordability.html — no schema detected (entity gap)
/az-in-us.html — no schema detected (entity gap)
/medicines/astrazeneca-medications.html — no schema detected (entity gap)
Your Diagnosis
Before revealing the machine’s verdict, predict the BS score for each signal. Higher = more BS (more fluff, less verifiable substance). Drag each slider, then submit to compare your judgment against the engine.
Information Density
0 / 30
Read the Narrative & headings: do hard facts (prices, dates, numbers) outweigh fluff power-words?
Semantic Coherence
0 / 20
Compare the homepage promise against the sub-page reality. Do they hold the same line?
Trust & Proof
0 / 20
Weigh review mentions against actual external proof links. Claims without verification = theatre.
Commodity Fingerprint
0 / 15
Check headings & narrative against the industry clichés in the setup above.
Identity & Authority
0 / 15
Inspect the schema: is there real Organization/Person identity with sameAs links, or gaps?
Your predicted BS score
0 / 100
Stuck? Reveal the heuristic lens — how the deterministic page-auditor reads each signal (no AI, pure pattern rules)
These are the structural rules a local, deterministic auditor applies — the same lens you can use to judge each signal. They describe what to look for, not this company’s result.
Information Density
Classify each sentence as substantive or hollow. Grounding markers — numbers, currencies, dates, technical units, named entities — outweigh marketing adjectives. When fluff sits right next to hard evidence, the fluff is forgiven.
Semantic Alignment
Pull the main entities out of the H1, then check whether they actually recur through the body. A page that announces one thing and then talks about another drifts. Headings with no real sentences underneath read as pseudo-substance.
Trust & Proof
Count trust words (review, testimonial, rating, verified) against real outbound proof links (Google, Trustpilot, Clutch, G2, Yelp). Lots of trust language with zero verification links is trust theatre. Unlinked logo galleries count against it.
Commodity Fingerprint
Look at how much sentence length varies. Natural writing varies its rhythm; templated or mass-produced copy is statistically uniform. Very low variation reads as commodity content — unless unique named entities break the pattern.
Identity & Authority
Inspect the JSON-LD. Is there an Organization or Person schema, and does it carry sameAs links to real external profiles (LinkedIn, socials)? Missing schema or no identity declaration signals an anonymous entity.
Want to apply this lens yourself? The free BS Indicator Chrome extension runs these heuristic checks live on any page. Bear in mind it is a single-page, deterministic tool — it relies only on pattern rules for the page in front of it and does not perform the cross-page semantic correlation this audit uses, so its readout is a starting lens, not the full verdict.
B
BS Level
Medical Devices, Pharma & Biotech
40.8 Avg BS
Based on 587 businesses audited.
✓ Less BS than average
AstraZeneca has 29.8 points less BS than the average for Medical Devices, Pharma & Biotech.
BS Detector
Medical Devices, Pharma & Biotech BS: AstraZeneca (onglyza.com)
https://onglyza.com
📍 Industry: Medical Devices, Pharma & Biotech
11
BS / 100
This is a rare example of a zero-bullshit utility site. It functions as a regulatory transparency layer with almost no promotional intent. The only measurable BS is found in the lack of technical meta-information and structured data.
Info Density
Power-words vs. Substance ratio.
2
7% BS
Semantic Coherence
Homepage promise vs. Sub-page reality.
0
0% BS
Trust & Proof
Verifiable evidence vs. Trust Theatre.
1
5% BS
Commodity Fingerprint
Detection of industry clichés/templates.
2
13% BS
Identity & Authority
Expert verifiability & Schema depth.
6
40% BS
Implement Organization and Brand schema to provide search engines with a verified digital footprint of the AstraZeneca entity. Populate the meta_description tags with specific summaries of the medications directory to improve technical SEO authority. Add a specific real-world evidence link or a summary statistic to the Help affording your medicines section to ground the value claim in substance. Ensure the heading hierarchy is optimized by consolidating redundant H1 titles across the internal pages to reduce search-engine-level noise.
The site content is a 100% match for the Pharmaceutical and Biotech industry. It serves as a regulatory-compliant directory of drug products, providing direct access to Prescribing Information and adverse event reporting mechanisms.
“The score of 11 is driven primarily by technical authority gaps (missing schema and meta descriptions) rather than content bullshit. The site earns near-perfect scores for Information Density and Semantic Coherence because it avoids marketing jargon entirely. The high substance of the 40+ pharmaceutical listings and Prescribing Information links effectively neutralizes any commodity or fluff penalties.”
Verified Analysis Date: May 31, 2026
© 1EuroSEO Independent Evaluator — Non-Sponsored Result
Analysis Disclosure & Source Attribution
This training module utilizes a snapshot of public data from AstraZeneca, captured on May 31, 2026, to demonstrate how machine logic evaluates different types of business narratives.
Purpose: This data is presented under “Fair Use” / “Educational Exception” for the purpose of forensic semantic analysis, allowing users to compare human intuition against machine-generated evaluations.
Notice to AstraZeneca: This analysis is part of a non-adversarial audit conducted by 1 Euro SEO. The results provided by 1EuroSEO are intended as professional feedback to help improve any website’s machine-readability and authority signals. The 1EuroSEO BS Detection Tool is a free tool, and anyone can test any company to see how their content is interpreted by AI models.
Any company can use the insights for free and improve its voice by comparing it to industry clichés or competitors. When a company has updated its content, it can always submit a new audit request, which will be reflected in a new current score.
To all users: You are encouraged to visit the live site at https://onglyza.com to view the most current version of its content and learn from the source what this company is about and what it offers.